Liposome in Cosmetics Market to Reach $1,572.9 Million by 2035
Liposome in cosmetics market is driven by the increasing demand for advanced skincare formulations, growing consumer preference for premium beauty products, and rising adoption of encapsulation technologies in cosmetic applications. Liposome-based ingredients are gaining popularity due to their ability to enhance the delivery and absorption of active compounds such as vitamins, ceramides, and CoQ10 in skincare and haircare products. Additionally, the growing focus on anti-aging solutions, clean beauty trends, and innovations in cosmetic formulations are further supporting the growth of the global liposome in cosmetics market.
Browse the full report description of “Liposome in Cosmetics Market Size, Share & Trends Analysis by Type (Liposome Vitamin, Liposome Ceramide, Liposome CoQ10, and Others), By Application (Skin Care, and Hair Care), By Formulation (Creams, Lotions, Gels, Serums, and Others), By Distribution Channel (Online Stores, Supermarkets/Hypermarkets, Specialty Stores, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/liposome-in-cosmetics-market
Regenerative and exosome-based skincare segment is expected to account for a major market share in 2026
Regenerative and exosome-based skincare products are expected to hold a major market share in 2026, primarily due to increasing demand for advanced aesthetic treatments, anti-aging solutions, and biologically active cosmetic formulations. Companies including PMGC Holdings, Elevai Labs, and ARCHIMED are actively expanding regenerative skincare portfolios through acquisitions, commercialization initiatives, and advanced cosmetic technology development. The growing adoption of exosome, liposome, and growth factor-based skincare solutions is a key factor driving segment demand. Increasing consumer preference for science-backed cosmetic products and minimally invasive aesthetic treatments is further supporting market growth globally.
Liposome and nano-delivery cosmetic formulation technologies segment is expected to witness significant growth in 2026
Liposome and nano-delivery cosmetic formulation technologies are expected to witness significant growth in 2026, driven by increasing innovation in targeted skincare delivery systems and advanced topical cosmetic formulations. PMGC Holdings completed the divestiture of Elevai Skincare to Carmell Corporation in 2025, strengthening Carmell’s regenerative skincare and aesthetic medicine business. The transaction expanded capabilities related to lipid-based and nano-delivery cosmetic technologies for advanced skincare applications. Growing demand for enhanced ingredient absorption, long-lasting efficacy, and precision skincare treatments is accelerating adoption of advanced cosmetic delivery technologies across the beauty and aesthetics industry.
Medical aesthetics and biologically active skincare technologies segment is expected to expand rapidly in 2026
Medical aesthetics and biologically active skincare technologies are expected to expand rapidly in 2026, supported by rising investment in regenerative cosmetic products and next-generation skincare science. Elevai Labs established Elevai Skincare and Elevai Biosciences subsidiaries in 2024 to expand commercialization of exosome and liposome-based skincare technologies. Additionally, ARCHIMED acquired a majority stake in Cellese in 2024 to strengthen its position in regenerative cosmetic technologies under the AnteAGE brand. Increasing demand for advanced anti-aging products, regenerative aesthetics, and clinically driven skincare solutions is expected to further accelerate growth in biologically active skincare technologies.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404